Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-07-19

FDA Approved: ASENAPINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for asenapine from Alembic Pharmaceuticals Limited, resulting in updated labeling for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

SUPPL AP for ASENAPINE (ASENAPINE)